SCHEMBL5500196

SCHEMBL5500196

O=C(O)C(=Cc1ccc(O)c(O)c1)NC(=O)c1ccc(O)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.49
MAPT P10636 5/20 0.48
KDM4E B2RXH2 4/20 0.48
EGFR P00533 3/20 0.48
POLB P06746 3/20 0.48
HSD17B10 Q99714 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ERBB2 P04626 2/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
HPGD P15428 2/20 0.48
APEX1 P27695 2/20 0.48
MAPK1 P28482 2/20 0.48
PMP22 Q01453 2/20 0.48
KMT2A Q03164 2/20 0.48
HIF1A Q16665 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
RGS12 O14924 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500195 1.00 HDAC6 (0.49) HDAC6MAPTKDM4EEGFRPOLB
SCHEMBL11055554 0.81 IAPP (0.51) HDAC6MAPTKDM4EEGFRPOLB
SCHEMBL11055553 0.81 IAPP (0.51) HDAC6MAPTKDM4EEGFRPOLB
SCHEMBL140158 0.79 EGFR (0.50) MAPTKDM4EEGFRHSD17B10ERBB2
SCHEMBL140953 0.79 EGFR (0.50) MAPTKDM4EEGFRHSD17B10ERBB2
SCHEMBL108595 0.79 EGFR (0.50) MAPTKDM4EEGFRHSD17B10ERBB2
SCHEMBL140159 0.78 DNM1 (0.41) HDAC6MAPTKDM4EEGFRPOLB
SCHEMBL27828053 0.76 HDAC6 (0.72) HDAC6MAPTKDM4EPOLBL3MBTL1
SCHEMBL8424974 0.74 KDM4E (0.61) MAPTKDM4EPOLBMEN1ALDH1A1
SCHEMBL8424978 0.74 KDM4E (0.61) MAPTKDM4EPOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP claimed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO claimed
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP disclosed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO disclosed